标题
The discovery and development of sorafenib for the treatment of thyroid cancer
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume 10, Issue 4, Pages 427-439
出版商
Informa Healthcare
发表日期
2015-02-09
DOI
10.1517/17460441.2015.1006194
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prognostic Value of Genetic Mutations in Thyroid Cancer: A Meta-Analysis
- (2015) Kyoungjune Pak et al. THYROID
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma
- (2014) Nishant Agrawal et al. CELL
- Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis
- (2014) Manabu Morimoto et al. HEPATOLOGY RESEARCH
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- Sorafenib in Metastatic Thyroid Cancer: A Systematic Review
- (2014) L. Thomas et al. ONCOLOGIST
- Management of Sorafenib-Related Adverse Events: A Clinician’s Perspective
- (2014) Marcia S. Brose et al. SEMINARS IN ONCOLOGY
- Concomitant RAS, RET/PTC, or BRAF Mutations in Advanced Stage of Papillary Thyroid Carcinoma
- (2014) Minjing Zou et al. THYROID
- Sorafenib and Thyroid Cancer
- (2013) Poupak Fallahi et al. BIODRUGS
- Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
- (2013) Mingzhao Xing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Progress in molecular-based management of differentiated thyroid cancer
- (2013) Mingzhao Xing et al. LANCET
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) B. Escudier et al. ANNALS OF ONCOLOGY
- Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolites
- (2012) Sussan Ghassabian et al. BIOCHEMICAL PHARMACOLOGY
- Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET
- (2012) Vincenzo Marotta et al. CLINICAL ENDOCRINOLOGY
- Sorafenib in metastatic thyroid cancer
- (2012) Jaume Capdevila et al. ENDOCRINE-RELATED CANCER
- Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial
- (2012) T C Schneider et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Variability of Sorafenib Toxicity and Exposure over Time: A Pharmacokinetic/Pharmacodynamic Analysis
- (2012) P. Boudou-Rouquette et al. ONCOLOGIST
- Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
- (2012) Olivier Mir et al. PLoS One
- Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
- (2012) Panayiotis Savvides et al. THYROID
- Meta-analysis of dermatological toxicities associated with sorafenib
- (2011) L. Zhang et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Skin Tumors Induced by Sorafenib; Paradoxic RAS-RAF Pathway Activation and Oncogenic Mutations of HRAS, TP53, and TGFBR1
- (2011) J. P. Arnault et al. CLINICAL CANCER RESEARCH
- Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population
- (2011) Merina Ahmed et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Cytotoxic Chemotherapy for Differentiated Thyroid Carcinoma
- (2010) S.I. Sherman CLINICAL ONCOLOGY
- Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
- (2010) Elaine T. Lam et al. JOURNAL OF CLINICAL ONCOLOGY
- Hand-Foot Skin Reaction Increases with Cumulative Sorafenib Dose and with Combination Anti-Vascular Endothelial Growth Factor Therapy
- (2009) N. S. Azad et al. CLINICAL CANCER RESEARCH
- Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
- (2009) Hendrieke Hoftijzer et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
- (2009) Antonius A. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
- (2009) Richard T. Kloos et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials
- (2009) Youjin Je et al. LANCET ONCOLOGY
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
- (2009) David S. Cooper et al. THYROID
- Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification
- (2008) Rebecca E. Schweppe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search